GLASF
1 tracked call · 1 long · 0 short · last 90d: 1L/0S
first called by The Real Eisman Playbook 1mo ago
LONG1mo ago
“The reclassification by the Trump administration of medical cannabis from a Schedule I to a Schedule III drug will improve growth and earnings. I own the stock”The Real Eisman Playbook · Steve Eisman
Glass House Brands gains as cannabis rescheduling lifts cannabis growth and earnings
GLASFLONG@ $13.35
$11.78-11.76%
since call Jun 18